The September issue of PIP has now been published and is available to read online.
Click here to read the September issue of Pathology in Practice
EDITOR’S COMMENT:
Questions and answers
Welcome to the September issue of Pathology in Practice and if it feels slightly chunkier than usual then that can mean only one thing – IBMS Congress is here! Hot on the heels of a larger-than-normal August issue, the one you’re currently holding is even bigger again – a testament to the importance of the event to our readers, authors, advertisers, along with my colleagues at Step Communications.
With significant changes across the NHS to come over the next year or two, it’s worth pausing for a moment to consider where we will be at the time of the next Congress in 2027. Will changes designed to encourage adoption of new technology mean that a greater proportion than before of the novel diagnostic tools on show at the trade exhibition will be in use for the benefit of patients by the time of the next event? Will the newly enlarged Department of Health and Social Care be safely guiding the hospitals and medical teams of the UK? Will joined up digital pathology networks be used for the benefit both of patients and a rejuvenated pathology workforce?
We probably won’t get answers to all the burning questions, but there will no doubt be lots to discover, both in the exhibition and the myriad lectures and presentations which make up Congress’ leading scientific programme.
I am very much looking forward to what will be my second Congress. Going into my fourth year with PiP I certainly know more than I did two years ago, but am very aware there’s lots for everyone to discover and learn. Please do drop by our stand in the foyer area if you have any thoughts or comments on either the magazine or Congress to share.
To pass the days until Congress arrives this issue has a wide spread of articles to broaden your knowledge. Subjects include plasma viscosity to diagnose long COVID, the future of newborn screening, a report looking at 20 years of data from EQA of blood gas analysers, Stephen MacDonald’s latest article on risk analysis, and measures to optimise the pre-analytic phase for pathology samples.
I’m also pleased that this issue has an Opinion article from IBMS Chief Executive David Wells. His piece on a recent report that was produced in collaboration with the IBMS underlines the important work done by the Institute on behalf of the biomedical science profession, and by extension to improve healthcare for NHS patients across the country.
Enjoy the issue, and if you’re there make the most of the learning opportunity offered by IBMS Congress. [email protected]